Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing

G. J. van Baaren, M. M. C. Bruijn, B. W. Mol

Research output: Contribution to journalComment/Letter to the editorAcademic

Cite this